Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.416 USD | +0.22% | -12.51% | +81.26% |
06-06 | UpHealth, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-21 | UpHealth, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Capitalization 1 | 323.1 | 24.54 | 4.245 | 7.876 | - |
Enterprise Value (EV) 1 | 323.1 | 24.54 | 4.245 | 7.876 | 7.876 |
P/E ratio | -0.7 x | -0.11 x | -0.07 x | - | - |
Yield | - | - | - | - | - |
Capitalization / Revenue | 2.61 x | 0.15 x | 0.03 x | 0.16 x | 0.15 x |
EV / Revenue | 2.61 x | 0.15 x | 0.03 x | 0.16 x | 0.15 x |
EV / EBITDA | -81 x | 7.54 x | 0.22 x | 0.72 x | 0.64 x |
EV / FCF | - | - | - | - | - |
FCF Yield | - | - | - | - | - |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 14,425 | 15,054 | 18,501 | 18,932 | - |
Reference price 2 | 22.40 | 1.630 | 0.2294 | 0.4160 | 0.4160 |
Announcement Date | 18/04/22 | 02/03/23 | 21/03/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net sales 1 | 123.8 | 158.8 | 130 | 48.8 | 52.3 |
EBITDA 1 | -3.99 | 3.256 | 19.56 | 10.9 | 12.3 |
EBIT | -82.05 | -161.4 | -89.57 | - | - |
Operating Margin | -66.28% | -101.63% | -68.9% | - | - |
Earnings before Tax (EBT) | -342.8 | -232.3 | -57.63 | - | - |
Net income | -341 | -223 | -57.84 | - | - |
Net margin | -275.47% | -140.43% | -44.49% | - | - |
EPS | -31.90 | -15.17 | -3.260 | - | - |
Free Cash Flow | - | - | - | - | - |
FCF margin | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 18/04/22 | 02/03/23 | 21/03/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 33.9 | 35.97 | 43.67 | 38.67 | 40.5 | 42.14 | 37.82 | 32.68 | 17.35 | - | 12.3 | 12 | 12.5 | 12.7 | 13.3 |
EBITDA 1 | -12.54 | -1.3 | 3.954 | -1.247 | 1.853 | 6.564 | 5.255 | 5.418 | 2.317 | - | 2.9 | 2.7 | 3 | 3 | 3.2 |
EBIT | -39.02 | -17.91 | -10.04 | -120 | -13.41 | -0.778 | -10.74 | -72.79 | -5.263 | -5.37 | - | - | - | - | - |
Operating Margin | -115.09% | -49.79% | -23% | -310.43% | -33.11% | -1.85% | -28.4% | -222.73% | -30.34% | - | - | - | - | - | - |
Earnings before Tax (EBT) | -338.1 | -20 | -14.7 | -178.8 | -18.82 | -7.635 | -17.75 | -20.14 | -12.11 | - | - | - | - | - | - |
Net income | -336 | -17.44 | -12.44 | -165.8 | -27.36 | -8.083 | -19.13 | -20.6 | -10.02 | - | - | - | - | - | - |
Net margin | -991.15% | -48.5% | -28.48% | -428.7% | -67.55% | -19.18% | -50.57% | -63.05% | -57.78% | - | - | - | - | - | - |
EPS | -23.60 | -1.200 | -0.9000 | -11.17 | -1.820 | -0.5100 | -1.050 | -1.120 | -0.5400 | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 18/04/22 | 23/05/22 | 15/08/22 | 29/12/22 | 02/03/23 | 11/05/23 | 10/08/23 | 20/11/23 | 21/03/24 | 06/06/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net Debt | - | - | - | - | - |
Net Cash position | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex | - | - | - | - | - |
Capex / Sales | - | - | - | - | - |
Announcement Date | 18/04/22 | 02/03/23 | 21/03/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+81.26% | 7.88M | |
-1.30% | 27.42B | |
+11.39% | 21.31B | |
+109.79% | 2.32B | |
-8.59% | 2.12B | |
-34.41% | 1.57B | |
-2.86% | 1.24B | |
-21.86% | 1.19B | |
-13.24% | 1.12B | |
-9.05% | 1.15B |
- Stock Market
- Equities
- UPHL Stock
- Financials UpHealth, Inc.